Dov Hass is an associate in Morgan Lewis's Business and Finance Practice. Mr. Hass’s practice focuses on venture capital financings, acquisitions, divestitures and mergers, joint ventures and strategic partnerships, and providing general corporate and securities representation to emerging growth and life science companies.

As a significant part of his practice, Mr. Hass represents pharmaceutical and biotechnology companies in transactions such as the negotiation and structuring of strategic alliances and other collaborations, licensing transactions, supply and distribution arrangements, co-promotion arrangements, and joint ventures. He also advises companies from a broad range of industries on general corporate and transactional matters.

Mr. Hass earned his J.D. from Fordham University School of Law in 2005. Prior to attending law school, he was a conference director for the Institute for International Research's biopharmaceutical division, where he produced conferences for the pharmaceutical and biotechnology industries. Mr. Hass also served as a healthcare investment banking analyst in the private placement group of Ladenburg Thalmann, where he focused on the biotechnology industry.

Mr. Hass is admitted to practice in New Jersey and New York.